Table 2.
Patient characteristics | Aneurysm characteristics | Treatment characteristics | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Patient | Agea [years] |
Risk factors | SAH | Location | Morphology | Max. diameter [mm] |
Parent artery mean diameter [mm] |
FDS | Periinterventional antiplatelet therapy | Technique | Time between FDS deployment and thrombosis [min] |
1 | 60 | aHT | No | Intradural ICA | Saccular | 24.9 | 3.1 | FRED | ASA + Clopi | FDS + coiling | 14 |
2 | 50 | aHT, HCho, smoke | No | ACA | Saccular | 3.8 | 2.0 | FRED Jr | ASA + Clopi | FDS | 30 |
3 | 70 | aHT, HCho, smoke | No | Intradural ICA | Saccular | 6.9 | 2.6 | FRED | ASA + Clopi | FDS | 17 |
4 | 40 | aHT, HCho, smoke | No | ACOM | Saccular | 5.6 | 2.2 | FRED Jr | ASA + Clopi | FDS | 5 |
5 (2 aneurysms) |
60 | aHT | No | Extradural ICA (both) | Saccular (both) | 4.5; 2.5 | 4.0 | FRED | ASA + Tica | FDS | 10 |
6 | 50 | aHT, smoke | No | Vertebrobasilar | Dissecting | 5.5 | 2.2 | FRED Jr | ASA + Clopi | FDS | 30 |
7 | 60 | aHT, HCho, smoke |
Yes, > 2 weeks |
Intradural ICA | Saccular | 3.5 | 3.6 | FRED | Tirofiban | FDS | 10 |
8 | 70 | aHT, HCho, smoke | No | Extradural ICA | Saccular | 15.5 | 3.8 | FRED | ASA + Clopi | FDS + coiling | 11 |
9 | 50 | aHT, HCho, smoke | No | MCA | Saccular | 11.0 | 2.9 | FRED X | ASA + Pra | FDS | 18 |
10 | 70 | aHT | No | Intradural ICA | Saccular | 7.1 | 3.9 | FRED X | ASA + Clopi | FDS + coiling | 24 |
11 | 70 | aHT, HCho, smoke | No | Intradural ICA | Saccular | 4.7 | 3.9 | FRED X | ASA + Clopi | FDS + coiling | 18 |
12 | 70 | aHT, HCho | No | Intradural ICA | Fusiform | 19.7 | 3.8 | PED Vantage Shield | ASA + Clopi | FDS + coiling | 6 |
F female, M male, aHT arterial hypertension, HCho hypercholesterolemia, SAH subarachnoid hemorrhage, ICA internal carotid artery, ACA anterior carotid artery, ACOM anterior communicating artery, MCA middle cerebral artery, no. number, FDS flow diverter stent, ASA aspirin, Clopi clopidogrel, Tica ticagrelor, Pra prasugrel
a Exact age is not reported for anonymization purpose.